Literature DB >> 12419313

The beta2-adaptin clathrin adaptor interacts with the mitotic checkpoint kinase BubR1.

Corinne Cayrol1, Céline Cougoule, Michel Wright.   

Abstract

The adaptor AP2 is a heterotetrameric complex that associates with clathrin and regulatory proteins to mediate rapid endocytosis from the plasma membrane. Here, we report the identification of the mitotic checkpoint kinase BubR1 as a novel binding partner of beta2-adaptin, one of the AP2 large subunits. Using two-hybrid experiments and in vitro binding assays, we show that beta2-adaptin binds to BubR1 through its amino-terminal beta2-'trunk' domain, while the beta2-binding region of BubR1 maps to the carboxy-terminal kinase domain. Subcellular immunolocalization studies suggest that the interaction between BubR1 and beta2-adaptin could take place in the cytosol at any time during the cell cycle. In addition, we found that BubR1 and the BubR1-related kinase, Bub1, also bind to beta-adaptins of other AP complexes. Together, these results support a model in which the mitotic checkpoint kinases BubR1 and BuB1, by binding to beta-adaptins, may play novel roles in the regulation of vesicular intracellular traffic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419313     DOI: 10.1016/s0006-291x(02)02522-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Novel functions of endocytic player clathrin in mitosis.

Authors:  Wenxiang Fu; Qing Jiang; Chuanmao Zhang
Journal:  Cell Res       Date:  2011-06-28       Impact factor: 25.617

2.  The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling.

Authors:  Shyam Nyati; Katrina Schinske-Sebolt; Sethuramasundaram Pitchiaya; Katerina Chekhovskiy; Areeb Chator; Nauman Chaudhry; Joseph Dosch; Marcian E Van Dort; Sooryanarayana Varambally; Chandan Kumar-Sinha; Mukesh Kumar Nyati; Dipankar Ray; Nils G Walter; Hongtao Yu; Brian Dale Ross; Alnawaz Rehemtulla
Journal:  Sci Signal       Date:  2015-01-06       Impact factor: 8.192

3.  Mechanisms regulating targeting of recycling endosomes to the cleavage furrow during cytokinesis.

Authors:  Glenn C Simon; Rytis Prekeris
Journal:  Biochem Soc Trans       Date:  2008-06       Impact factor: 5.407

Review 4.  Mitotic moonlighting functions for membrane trafficking proteins.

Authors:  Stephen J Royle
Journal:  Traffic       Date:  2011-03-24       Impact factor: 6.215

5.  Identification of novel mitosis regulators through data mining with human centromere/kinetochore proteins as group queries.

Authors:  Aaron R Tipton; Kexi Wang; Peter Oladimeji; Shermeen Sufi; Zhidong Gu; Song-Tao Liu
Journal:  BMC Cell Biol       Date:  2012-06-19       Impact factor: 4.241

6.  Bub1 Facilitates Virus Entry through Endocytosis in a Model of Drosophila Pathogenesis.

Authors:  Shuo Yang; Junjing Yu; Zhiqin Fan; Si-Tang Gong; Hong Tang; Lei Pan
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

7.  Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling.

Authors:  Eunhee Choi; Sotaro Kikuchi; Haishan Gao; Karolina Brodzik; Ibrahim Nassour; Adam Yopp; Amit G Singal; Hao Zhu; Hongtao Yu
Journal:  Nat Commun       Date:  2019-04-01       Impact factor: 14.919

8.  Mitotic Checkpoint Regulators Control Insulin Signaling and Metabolic Homeostasis.

Authors:  Eunhee Choi; Xiangli Zhang; Chao Xing; Hongtao Yu
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

9.  RNAi screening reveals a large signaling network controlling the Golgi apparatus in human cells.

Authors:  Joanne Chia; Germaine Goh; Victor Racine; Susanne Ng; Pankaj Kumar; Frederic Bard
Journal:  Mol Syst Biol       Date:  2012       Impact factor: 11.429

10.  TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling.

Authors:  Shyam Nyati; Brandon S Gregg; Jiaqi Xu; Grant Young; Lauren Kimmel; Mukesh K Nyati; Dipankar Ray; Corey Speers; Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2020-03-03       Impact factor: 5.715

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.